Jacek Gronwald

Jacek Gronwald is a Professor at the Department of Genetics and Pathomorphology within the Faculty of Pharmacy, Medical Biotechnology and Laboratory Medicine at the Pomeranian Medical University in Szczecin. His work focuses on cancer genetics, oncology, and biomarker research, particularly in breast, ovarian, and endometrial cancers.

He holds a Doctorate (Ph.D.) awarded in 1996, though the specific institution is not detailed. His research integrates clinical, genetic, and biochemical approaches to understand cancer risk factors, treatment responses, and prognostic markers.

Key research interests include:

• BRCA1/BRCA2 mutation carriers and their cancer risks
• Biomarkers (e.g., trace elements like selenium, copper, and zinc) for cancer prognosis
• Impact of hormonal therapies and contraceptive use on cancer outcomes
• Genetic epidemiology of gynecological and breast cancers

His publications emphasize large-scale studies on cancer genetics, including genome-wide association studies (GWAS) and analyses of clinical trial data. Collaborations with consortia like the Ovarian Tumor Tissue Analysis (OTTA) and international genetic databases highlight his global research network.

No scientific awards are explicitly listed in the profile. His work on risk-adjusted cancer screening (RiskAP project) and diagnostic tools (e.g., AI-driven cytology scanners) underscores his translational research focus.

He has advised no listed students, though his involvement in large cohort studies suggests mentorship in collaborative projects. Grants and funding sources are not detailed here.